The diagnostics startup is developing a testing platform that uses digital imaging and signal processing for pathogen identification and susceptibility determination.
Last week, readers were most interested in a story about BD's plan to separate its Biosciences and Diagnostics Solutions business by the end of 2026.
Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing ...
The digital pathology software developer is raising funding that would help it to increase its headcount and support its Aiosyn Mitosis Breast application.
NEW YORK — MRC Holland said on Thursday that its blood-based assay for Temple, Kagami-Ogata, and Russell-Silver syndromes has received certification under Europe's In Vitro Diagnostic Regulation (IVDR ...
The company said that growth in its diagnostics business was partly offset by declines in the Americas and China.
Total revenues were $3.33 billion, up from $3.03 billion in the same quarter last year and slightly above the consensus Wall Street estimate of $3.31 billion.
The company said that its molecular diagnostics revenues rose 7 percent on the strength of its women's health assays and Biotheranostics business.
Imagene's AI-based multigene panel for predicting non-small cell lung cancer biomarkers from biopsy images will be combined with Tempus' real-world data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback